Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Donald Bodenner

Concepts (247)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Neoplasms
14
2017
152
2.330
 Why?
Thyroidectomy
13
2019
101
2.130
 Why?
Parathyroidectomy
8
2018
78
1.520
 Why?
Thyroid Diseases
6
2019
36
1.510
 Why?
Parathyroid Neoplasms
5
2015
45
1.320
 Why?
Thyroid Gland
7
2017
88
1.250
 Why?
Vitamin D Deficiency
5
2019
45
1.180
 Why?
Adenoma
4
2017
146
1.130
 Why?
Parathyroid Hormone
8
2019
220
1.110
 Why?
Vitamin D
4
2015
93
1.000
 Why?
Fluorodeoxyglucose F18
6
2013
199
0.910
 Why?
Positron-Emission Tomography
7
2013
311
0.880
 Why?
Carcinoma, Papillary
4
2017
66
0.860
 Why?
Ambulatory Surgical Procedures
4
2014
56
0.850
 Why?
Radiopharmaceuticals
7
2015
252
0.840
 Why?
Hyperparathyroidism, Primary
4
2018
53
0.780
 Why?
Hyperparathyroidism
2
2015
50
0.720
 Why?
Iodine Radioisotopes
3
2015
50
0.700
 Why?
Megestrol Acetate
2
2007
18
0.660
 Why?
Parathyroid Diseases
2
2016
9
0.650
 Why?
Bone Density Conservation Agents
2
2007
82
0.620
 Why?
Nursing Homes
2
2007
128
0.610
 Why?
Incidental Findings
3
2013
44
0.600
 Why?
Proton Pump Inhibitors
1
2015
89
0.580
 Why?
Diphosphonates
1
2015
97
0.570
 Why?
Thyroglobulin
2
2013
11
0.560
 Why?
Academic Medical Centers
2
2012
156
0.550
 Why?
Carcinoma, Medullary
2
2010
15
0.530
 Why?
Parathyroid Glands
5
2018
35
0.530
 Why?
Aged
19
2017
10017
0.500
 Why?
Middle Aged
25
2017
13149
0.490
 Why?
Hypothyroidism
2
2011
49
0.490
 Why?
Retrospective Studies
14
2019
5676
0.480
 Why?
Calcitonin
2
2010
40
0.460
 Why?
Postoperative Complications
5
2018
1005
0.440
 Why?
Male
31
2019
27231
0.440
 Why?
Carcinoma
2
2012
152
0.420
 Why?
Humans
44
2019
50276
0.410
 Why?
Thyroid Nodule
3
2017
35
0.400
 Why?
Algorithms
1
2013
690
0.400
 Why?
Weight Loss
2
2009
249
0.370
 Why?
Female
29
2019
27910
0.360
 Why?
Appetite Stimulants
1
2007
7
0.350
 Why?
Cachexia
1
2007
24
0.340
 Why?
Teriparatide
1
2007
16
0.340
 Why?
Aged, 80 and over
9
2017
3496
0.320
 Why?
Four-Dimensional Computed Tomography
2
2017
31
0.320
 Why?
Pituitary Hormones, Anterior
1
2005
3
0.310
 Why?
Hypocalcemia
2
2016
15
0.310
 Why?
Phenylurea Compounds
2
2015
13
0.310
 Why?
Hormones
1
2005
66
0.300
 Why?
Calcium
3
2018
421
0.300
 Why?
Quinolines
2
2015
42
0.300
 Why?
Transcriptional Activation
1
2005
140
0.290
 Why?
Pituitary Gland
1
2005
73
0.290
 Why?
Osteoporosis
1
2007
185
0.290
 Why?
Receptors, Estrogen
1
2005
149
0.290
 Why?
Interleukin-6
1
2005
299
0.270
 Why?
Biopsy, Fine-Needle
5
2011
118
0.260
 Why?
Protein Kinase Inhibitors
2
2015
204
0.260
 Why?
NF-kappa B
1
2005
335
0.260
 Why?
Illinois
2
2013
17
0.250
 Why?
Treatment Outcome
8
2015
5421
0.230
 Why?
Adult
13
2017
13861
0.220
 Why?
Young Adult
7
2015
4120
0.200
 Why?
Gene Expression Regulation
1
2005
1117
0.200
 Why?
Aging
1
2005
740
0.200
 Why?
Hyperparathyroidism, Secondary
1
2019
9
0.200
 Why?
Follow-Up Studies
3
2013
2357
0.190
 Why?
Postoperative Period
3
2015
182
0.190
 Why?
Vitamins
2
2018
52
0.180
 Why?
Patient Discharge
3
2016
282
0.180
 Why?
Preoperative Care
2
2018
183
0.180
 Why?
Intraoperative Complications
1
2019
122
0.170
 Why?
Prospective Studies
2
2013
2349
0.170
 Why?
United States
5
2015
4825
0.160
 Why?
Insulin Resistance
2
2009
304
0.160
 Why?
Antineoplastic Agents
2
2015
1244
0.160
 Why?
Reoperation
1
2018
443
0.160
 Why?
Predictive Value of Tests
3
2015
1044
0.150
 Why?
Incidence
2
2011
1051
0.150
 Why?
Hypoparathyroidism
1
2015
8
0.150
 Why?
Carcinoma, Neuroendocrine
1
2015
28
0.150
 Why?
Creatinine
1
2015
161
0.150
 Why?
Costs and Cost Analysis
2
2014
103
0.150
 Why?
Tomography, Emission-Computed, Single-Photon
1
2015
59
0.150
 Why?
Adolescent
5
2015
6596
0.150
 Why?
Disease Progression
3
2015
867
0.150
 Why?
Lymph Nodes
1
2017
287
0.140
 Why?
Molecular Targeted Therapy
1
2015
134
0.140
 Why?
Ambulatory Care
1
2016
219
0.140
 Why?
Neoplasm Metastasis
2
2015
258
0.140
 Why?
Hospitals, University
1
2014
93
0.130
 Why?
Diagnosis, Differential
6
2018
1151
0.130
 Why?
Child, Preschool
2
2013
3972
0.130
 Why?
Exercise
2
2009
481
0.130
 Why?
Sensitivity and Specificity
2
2013
953
0.130
 Why?
Technetium
1
2012
10
0.130
 Why?
Hospitals, Teaching
1
2013
66
0.130
 Why?
Drug Administration Schedule
1
2013
420
0.120
 Why?
Preoperative Period
1
2012
61
0.120
 Why?
Outpatients
1
2013
105
0.120
 Why?
Administration, Oral
1
2013
459
0.120
 Why?
Radionuclide Imaging
1
2012
123
0.120
 Why?
Struma Ovarii
1
2012
5
0.120
 Why?
Hospital Charges
1
2012
51
0.120
 Why?
Liver
2
2009
1239
0.120
 Why?
Tumor Burden
1
2012
142
0.120
 Why?
Cost Savings
1
2012
73
0.120
 Why?
Child
3
2013
6482
0.120
 Why?
Patient Compliance
1
2013
265
0.120
 Why?
Clinical Competence
2
2018
430
0.120
 Why?
Ovariectomy
1
2012
128
0.120
 Why?
Prognosis
3
2015
2057
0.110
 Why?
Chromogranin A
1
2010
7
0.110
 Why?
Immunohistochemistry
2
2012
1129
0.110
 Why?
Radiation Monitoring
1
2010
9
0.110
 Why?
Radiosurgery
1
2011
103
0.100
 Why?
Checklist
1
2010
36
0.100
 Why?
Obesity
2
2009
1111
0.100
 Why?
Inpatients
1
2011
176
0.100
 Why?
Multiple Endocrine Neoplasia Type 2a
1
2009
6
0.100
 Why?
Databases, Factual
1
2013
677
0.100
 Why?
Fatal Outcome
1
2010
231
0.100
 Why?
Caloric Restriction
1
2009
40
0.100
 Why?
Dose-Response Relationship, Drug
1
2013
1550
0.100
 Why?
Intra-Abdominal Fat
1
2009
22
0.100
 Why?
Proto-Oncogene Proteins c-ret
1
2009
29
0.100
 Why?
Ultrasonography
4
2015
480
0.100
 Why?
General Surgery
1
2010
112
0.090
 Why?
Occupational Exposure
1
2010
137
0.090
 Why?
Receptors, Thyrotropin
1
2007
7
0.090
 Why?
Symporters
1
2007
20
0.090
 Why?
Adenoma, Oxyphilic
1
2007
17
0.090
 Why?
Blastomycosis
1
2008
61
0.090
 Why?
Whole Body Imaging
1
2007
26
0.090
 Why?
Anorexia
1
2007
9
0.090
 Why?
Adiposity
1
2009
138
0.090
 Why?
Ovarian Neoplasms
1
2012
441
0.090
 Why?
Calcifediol
1
2006
10
0.080
 Why?
Calcium Carbonate
1
2006
11
0.080
 Why?
DNA, Neoplasm
1
2007
177
0.080
 Why?
Practice Management, Medical
1
2006
13
0.080
 Why?
Medical Audit
1
2006
27
0.080
 Why?
Drug Utilization Review
1
2006
33
0.080
 Why?
Severity of Illness Index
1
2011
1063
0.080
 Why?
Cross-Sectional Studies
2
2014
1468
0.080
 Why?
Head
1
2006
74
0.080
 Why?
Geriatrics
1
2006
49
0.080
 Why?
Drug Monitoring
1
2006
90
0.080
 Why?
Promoter Regions, Genetic
2
2007
534
0.080
 Why?
Time Factors
3
2015
3352
0.080
 Why?
Otolaryngology
1
2006
53
0.080
 Why?
Body Mass Index
2
2009
676
0.080
 Why?
Progesterone Congeners
1
2005
6
0.080
 Why?
Neck
1
2006
112
0.080
 Why?
Freezing
1
2005
13
0.080
 Why?
Body Fat Distribution
1
2005
14
0.080
 Why?
Proportional Hazards Models
1
2007
450
0.080
 Why?
Fractures, Bone
1
2006
118
0.080
 Why?
Serum
1
2005
40
0.080
 Why?
Gene Expression Regulation, Neoplastic
1
2010
878
0.080
 Why?
Faculty, Medical
1
2006
103
0.070
 Why?
DNA Primers
1
2005
234
0.070
 Why?
Arkansas
2
2014
2133
0.070
 Why?
Survival Analysis
1
2007
787
0.070
 Why?
HeLa Cells
1
2005
296
0.070
 Why?
Reproducibility of Results
3
2017
1260
0.070
 Why?
Internship and Residency
1
2010
459
0.070
 Why?
Base Sequence
1
2005
719
0.070
 Why?
Infant
1
2012
3499
0.070
 Why?
Nuclear Proteins
1
2005
269
0.060
 Why?
ROC Curve
2
2015
253
0.060
 Why?
Protein Binding
1
2005
756
0.060
 Why?
Intraoperative Period
2
2015
54
0.060
 Why?
Patient Selection
2
2018
292
0.060
 Why?
Randomized Controlled Trials as Topic
1
2005
506
0.060
 Why?
Tomography, X-Ray Computed
3
2012
1235
0.050
 Why?
Glucagon
2
2009
32
0.050
 Why?
Thalidomide
1
2002
405
0.050
 Why?
Cohort Studies
2
2015
1444
0.050
 Why?
Cholecalciferol
1
2018
20
0.050
 Why?
Monitoring, Intraoperative
1
2019
67
0.050
 Why?
Medical History Taking
1
2018
57
0.050
 Why?
Hospitals, High-Volume
1
2018
33
0.050
 Why?
Lymphatic System
1
2017
17
0.040
 Why?
Methylene Blue
1
2017
13
0.040
 Why?
Animals, Genetically Modified
1
2017
50
0.040
 Why?
Risk Factors
1
2006
3860
0.040
 Why?
Pilot Projects
2
2010
766
0.040
 Why?
Societies, Medical
1
2018
190
0.040
 Why?
Coloring Agents
1
2017
85
0.040
 Why?
Mice, Inbred Strains
1
2017
207
0.040
 Why?
Proto-Oncogene Proteins B-raf
1
2017
87
0.040
 Why?
Recurrence
1
2018
688
0.040
 Why?
Insulin
2
2009
513
0.040
 Why?
Lymphatic Metastasis
1
2017
251
0.040
 Why?
Bone Density
1
2018
427
0.040
 Why?
Brachial Plexus
1
2015
14
0.040
 Why?
Retreatment
1
2015
54
0.040
 Why?
Technetium Tc 99m Sestamibi
1
2015
26
0.040
 Why?
Endocrinology
1
2015
12
0.040
 Why?
Axilla
1
2015
96
0.040
 Why?
Hematoma
1
2015
68
0.040
 Why?
Transplantation, Autologous
1
2015
459
0.030
 Why?
Neoplasm Staging
1
2015
792
0.030
 Why?
Hernia, Abdominal
1
2012
6
0.030
 Why?
Activating Transcription Factor 1
1
2012
19
0.030
 Why?
Delayed Diagnosis
1
2012
23
0.030
 Why?
Mutation
1
2017
1361
0.030
 Why?
Ribs
1
2010
23
0.030
 Why?
Feasibility Studies
1
2011
393
0.030
 Why?
Thoracotomy
1
2010
40
0.030
 Why?
Hypercalcemia
1
2010
38
0.030
 Why?
Mediastinal Neoplasms
1
2010
20
0.030
 Why?
Neck Dissection
1
2010
47
0.030
 Why?
Gas Chromatography-Mass Spectrometry
1
2009
86
0.020
 Why?
Octreotide
1
2009
17
0.020
 Why?
Hospitalization
1
2014
649
0.020
 Why?
Glucose Tolerance Test
1
2009
75
0.020
 Why?
Prevalence
1
2012
944
0.020
 Why?
Adiponectin
1
2009
74
0.020
 Why?
Absorptiometry, Photon
1
2009
169
0.020
 Why?
Postmenopause
1
2009
83
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2009
309
0.020
 Why?
Eye
1
2008
36
0.020
 Why?
Iodine
1
2007
11
0.020
 Why?
Multiple Myeloma
1
2002
2686
0.020
 Why?
Bone Neoplasms
1
2010
194
0.020
 Why?
Methylation
1
2007
139
0.020
 Why?
Neoplasm Recurrence, Local
1
2011
576
0.020
 Why?
Overweight
1
2009
195
0.020
 Why?
Current Procedural Terminology
1
2006
10
0.020
 Why?
Insurance, Health, Reimbursement
1
2006
29
0.020
 Why?
Body Weight
1
2009
577
0.020
 Why?
Office Visits
1
2006
48
0.020
 Why?
Mice
1
2017
6232
0.020
 Why?
Polymerase Chain Reaction
1
2007
532
0.020
 Why?
Blood Glucose
1
2009
484
0.020
 Why?
Genetic Predisposition to Disease
1
2009
564
0.020
 Why?
Risk Assessment
1
2010
1387
0.020
 Why?
Lung
1
2008
483
0.020
 Why?
Thyroid Function Tests
1
2002
27
0.020
 Why?
Muscle, Skeletal
1
2009
813
0.020
 Why?
Thyrotropin
1
2002
42
0.020
 Why?
Animals
1
2017
14247
0.010
 Why?
Clinical Trials as Topic
1
2002
483
0.010
 Why?
Bodenner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (247) concept(s)
_
Co-Authors Expand Description
See all (17) people
_
Similar People Expand Description
See all (25) people
_
Same Department Expand Description
Search Department